Table 3.
Response to TkI treatment* | n | OR | 95% CI | P‐value | ||
---|---|---|---|---|---|---|
Codominant model | PR | AA | 23 | 1 | — | Ref. |
AG | 42 | 0.50 | 0.09–2.80 | 0.43 | ||
GG | 13 | 0.39 | 0.05–2.62 | 0.33 | ||
SD | AA | 10 | 1 | — | Ref. | |
AG | 4 | 0.08 | 0.01–0.60 | 0.01 | ||
GG | 4 | 0.19 | 0.02–1.58 | 0.12 | ||
Recessive model | PR | AA | 23 | 1 | — | Ref. |
AG + GG | 55 | 0.47 | 0.91–2.44 | 0.37 | ||
SD | AA | 10 | 1 | — | Ref. | |
AG + GG | 8 | 0.12 | 0.20–0.72 | 0.02 |
Bold P‐values indicate P ≤ 0.05 from multivariate analysis by multinomial adjusted by age, TNM and PS‐ECOG. Reference category: DP, disease progression.
PR, partial response; SD, stable disease; Ref., reference category.
*According to RECIST criteria.